Thai badminton player Pitchamon Opatniputh received a provisional doping suspension from the Asian Games after returning a positive test for a banned substance, according to the International Testing Agency (ITA). The 19-year-old athlete, ranked 18th in the world, tested positive for furosemide from an out-of-competition sample collected on September 17, as reported by Devdiscourse.
Provisional Suspension Issued Ahead of Team Competition
The suspension was enacted with immediate effect under the World Anti-Doping Code and the OCA Anti-Doping Rules, according to the ITA. Opatniputh was scheduled to compete in Thailand’s team event against China on a Tuesday, but the ruling forces her out of all tournament activities.
The ITA stated that the provisional ban prevents Opatniputh from competing, training, coaching, or participating in any capacity during the Asian Games Aichi-Nagoya 2026. The continental multi-sport event runs through October 4 across Aichi Prefecture and Nagoya, Japan.
Understanding Furosemide and the Testing Timeline
The sample that triggered the adverse analytical finding was gathered out-of-competition by testing officials on September 17.
Under standard anti-doping procedures, athletes facing provisional suspensions retain specific procedural rights. Opatniputh holds the option to request an analysis of her back-up B-sample and can challenge the provisional suspension directly at the Court of Arbitration for Sport (CAS), according to the ITA.
Next Steps in the Anti-Doping Process
The case remains pending a final resolution under the governance of the World Anti-Doping Code and the Olympic Council of Asia Anti-Doping Rules. Further updates regarding the status of the B-sample analysis or potential CAS proceedings will be issued by anti-doping authorities as the matter develops.
Keep reading
